Trial intelligence / Profile preview

Phase 2 study of intra-articular PTP-001 for knee osteoarthritis

2021-003395-13Phase 2Completed

Sponsor
Bioventus
Start
Nov 2021
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of motys in knee osteoarthritis (OA) and osteoarthritis (OA) (3 arms), sponsored by Bioventus. Primary endpoint: Change from pretreatment baseline in WOMAC pain sub-score. Started Nov 2021; status: completed.

02

Drugs

motys
03

Conditions

knee osteoarthritis (OA)osteoarthritis (OA)

Beyond the preview

Go deeper on 2021-003395-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-003395-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call